Annual Accounts Payable
$626.20 K
+$82.00 K+15.07%
June 30, 2024
Summary
- As of February 7, 2025, INM annual accounts payable is $626.20 thousand, with the most recent change of +$82.00 thousand (+15.07%) on June 30, 2024.
- During the last 3 years, INM annual accounts payable has fallen by -$148.90 thousand (-19.21%).
- INM annual accounts payable is now -46.30% below its all-time high of $1.17 million, reached on June 30, 2022.
Performance
INM Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$449.00 K
-$177.20 K-28.30%
September 30, 2024
Summary
- As of February 7, 2025, INM quarterly accounts payable is $449.00 thousand, with the most recent change of -$177.20 thousand (-28.30%) on September 30, 2024.
- Over the past year, INM quarterly accounts payable has increased by +$46.40 thousand (+11.53%).
- INM quarterly accounts payable is now -73.69% below its all-time high of $1.71 million, reached on December 31, 2021.
Performance
INM Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
INM Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +15.1% | +11.5% |
| 3 y3 years | -19.2% | -61.5% |
| 5 y5 years | - | -51.7% |
INM Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -46.3% | +15.1% | -73.7% | +46.5% |
| 5 y | 5-year | -46.3% | +15.1% | -73.7% | +194.0% |
| alltime | all time | -46.3% | +2015.5% | -73.7% | >+9999.0% |
InMed Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $449.00 K(-28.3%) |
| Jun 2024 | $626.20 K(+15.1%) | $626.20 K(+55.5%) |
| Mar 2024 | - | $402.60 K(+31.4%) |
| Dec 2023 | - | $306.50 K(-19.3%) |
| Sep 2023 | - | $379.90 K(-30.2%) |
| Jun 2023 | $544.20 K(-53.3%) | $544.20 K(-26.2%) |
| Mar 2023 | - | $737.50 K(-4.3%) |
| Dec 2022 | - | $770.80 K(-29.7%) |
| Sep 2022 | - | $1.10 M(-6.0%) |
| Jun 2022 | $1.17 M(+50.4%) | $1.17 M(-30.4%) |
| Mar 2022 | - | $1.68 M(-1.8%) |
| Dec 2021 | - | $1.71 M(+35.9%) |
| Sep 2021 | - | $1.26 M(+62.0%) |
| Jun 2021 | $775.10 K(+9.7%) | $775.10 K(-2.5%) |
| Mar 2021 | - | $795.30 K(-14.5%) |
| Dec 2020 | - | $930.40 K(+509.3%) |
| Sep 2020 | - | $152.70 K(-78.4%) |
| Jun 2020 | $706.50 K(-0.9%) | $706.50 K(-46.1%) |
| Mar 2020 | - | $1.31 M(+9.6%) |
| Dec 2019 | - | $1.20 M(+15.8%) |
| Sep 2019 | - | $1.03 M(+106.6%) |
| Mar 2019 | - | $500.10 K(+23.8%) |
| Dec 2018 | - | $403.90 K(-11.6%) |
| Sep 2018 | - | $457.00 K(-35.9%) |
| Jun 2018 | $713.00 K(+150.9%) | $713.00 K(+44.7%) |
| Mar 2018 | - | $492.60 K(+108.9%) |
| Dec 2017 | - | $235.80 K(+54.3%) |
| Sep 2017 | - | $152.80 K(-46.2%) |
| Jun 2017 | $284.20 K(+11.9%) | $284.20 K(+15.6%) |
| Mar 2017 | - | $245.90 K(+244.9%) |
| Dec 2016 | - | $71.30 K(-46.0%) |
| Sep 2016 | - | $132.00 K(-48.0%) |
| Jun 2016 | $254.00 K(+338.7%) | $254.00 K(-6.4%) |
| Mar 2016 | - | $271.40 K(+64.9%) |
| Dec 2015 | - | $164.60 K(+22.6%) |
| Sep 2015 | - | $134.30 K(+132.0%) |
| Jun 2015 | $57.90 K(+0.3%) | $57.90 K(-69.7%) |
| Mar 2015 | - | $191.30 K(+19.6%) |
| Dec 2014 | - | $159.90 K(+58.2%) |
| Sep 2014 | - | $101.10 K(+75.2%) |
| Jun 2014 | $57.70 K | $57.70 K(-50.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $115.80 K(+205.5%) |
| Dec 2013 | - | $37.90 K(+419.2%) |
| Sep 2013 | - | $7300.00(-75.3%) |
| Jun 2013 | $29.60 K(-22.5%) | $29.60 K(+13.4%) |
| Mar 2013 | - | $26.10 K(+50.9%) |
| Dec 2012 | - | $17.30 K(-61.3%) |
| Sep 2012 | - | $44.70 K(+17.0%) |
| Jun 2012 | $38.20 K(-17.3%) | $38.20 K(+170.9%) |
| Mar 2012 | - | $14.10 K(+243.9%) |
| Dec 2011 | - | $4100.00(-91.2%) |
| Sep 2011 | - | $46.80 K(+1.3%) |
| Jun 2011 | $46.20 K(-95.9%) | $46.20 K(-95.7%) |
| Sep 2008 | - | $1.06 M(-5.8%) |
| Jun 2008 | $1.13 M(+19.8%) | $1.13 M(+6.4%) |
| Mar 2008 | - | $1.06 M(-8.4%) |
| Dec 2007 | - | $1.16 M(+21.1%) |
| Sep 2007 | - | $957.10 K(+1.5%) |
| Jun 2007 | $943.20 K(+13.7%) | $943.20 K(+11.4%) |
| Mar 2007 | - | $846.80 K(+13.5%) |
| Dec 2006 | - | $746.10 K(+115.4%) |
| Sep 2006 | - | $346.40 K(-58.2%) |
| Jun 2006 | $829.50 K(-5.9%) | $829.50 K(+11.4%) |
| Mar 2006 | - | $744.80 K(-4.7%) |
| Dec 2005 | - | $781.80 K(-0.2%) |
| Sep 2005 | - | $783.60 K(-11.1%) |
| Jun 2005 | $881.80 K(+97.0%) | $881.80 K(+6.6%) |
| Mar 2005 | - | $827.50 K(-32.2%) |
| Dec 2004 | - | $1.22 M(+134.7%) |
| Sep 2004 | - | $520.10 K(+16.2%) |
| Jul 2004 | $447.60 K(+75.2%) | $447.60 K(+13.8%) |
| Apr 2004 | - | $393.20 K(-14.9%) |
| Jan 2004 | - | $461.80 K(-2.9%) |
| Oct 2003 | - | $475.80 K(+86.2%) |
| Jul 2003 | $255.50 K(+243.4%) | $255.50 K(+367.1%) |
| Apr 2003 | - | $54.70 K(+6.6%) |
| Jan 2003 | - | $51.30 K(-2.3%) |
| Oct 2002 | - | $52.50 K(-29.4%) |
| Jul 2002 | $74.40 K(-84.9%) | $74.40 K(+1.2%) |
| Apr 2002 | - | $73.50 K(-57.2%) |
| Jan 2002 | - | $171.90 K(-11.8%) |
| Oct 2001 | - | $195.00 K |
| Jul 2001 | $493.00 K | - |
FAQ
- What is InMed Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals annual accounts payable year-on-year change?
- What is InMed Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals quarterly accounts payable year-on-year change?
What is InMed Pharmaceuticals annual accounts payable?
The current annual accounts payable of INM is $626.20 K
What is the all time high annual accounts payable for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high annual accounts payable is $1.17 M
What is InMed Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, INM annual accounts payable has changed by +$82.00 K (+15.07%)
What is InMed Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of INM is $449.00 K
What is the all time high quarterly accounts payable for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high quarterly accounts payable is $1.71 M
What is InMed Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, INM quarterly accounts payable has changed by +$46.40 K (+11.53%)